Merck Executives to Speak at Morgan Stanley Global Healthcare Conference
Merck, known as MSD outside of the US and Canada, announced that its chairman and CEO Robert M. Davis and Dr. Dean Y. Li, executive vice president and president of Merck Research Laboratories, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026.
The event is scheduled for 3:20 p.m. ET and investors, analysts, members of the media, and the general public are invited to listen to a live audio webcast via this link.